Sales & Marketing Partner Content KOLs For An Omnichannel World Consider the KOLs fronting your current initiatives.
Sales & Marketing Partner Content Who would your KOLs identify as Rising stars? To truly discover Rising Stars in a rapidly changing landscape that may no longer recognise traditional metrics – publication numbers, qualifications, involvement in trials, etc – with the
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
